Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Allergy Clin Immunol ; 132(4): 889-95.e1-3, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23987797

ABSTRACT

OBJECTIVES: This study investigated the cognitive and psychosocial outcomes in childhood survivors of hemophagocytic lymphohistiocytosis after hematopoietic stem cell transplantation. METHODS: Twenty-one children were assessed on standardized measures of cognitive and psychosocial functioning and compared with an unaffected sibling control group (n = 14). Parent and teacher reports were obtained to provide additional information. RESULTS: The average full-scale intelligence quotient for the patient cohort was 81 (95% CI, 72-90), which was significantly lower than both the population average of 100 (P = .001) and the average for the unaffected sibling control group (99.2, P = .002). Fifty-six percent of school-aged children were receiving additional support at school, with the majority needing high levels of support. These children also experienced significant psychosocial difficulties. Lower socioeconomic status was associated with poorer cognitive outcomes, but age at transplantation, time to transplantation, type of conditioning, and presence of mixed chimerism were not. Ten (48%) of 21 children had evidence of neurologic involvement at diagnosis, but surprisingly, this was not significantly associated with adverse neurologic outcomes, and some children who did not have any apparent neurologic involvement at diagnosis had severe learning difficulties at follow-up. CONCLUSIONS: In summary, childhood survivors of hemophagocytic lymphohistiocytosis are at risk of long-term cognitive and psychosocial difficulties. Prospective and systematic long-term follow-up of these patients is essential for early identification and effective management of these problems.


Subject(s)
Cognition Disorders/epidemiology , Hematopoietic Stem Cell Transplantation/adverse effects , Lymphohistiocytosis, Hemophagocytic/psychology , Lymphohistiocytosis, Hemophagocytic/therapy , Child , Child, Preschool , Female , Hematopoietic Stem Cell Transplantation/mortality , Humans , Infant , Learning Disabilities/epidemiology , Lymphohistiocytosis, Hemophagocytic/complications , Lymphohistiocytosis, Hemophagocytic/mortality , Male , Prospective Studies , Psychology , Surveys and Questionnaires , Survivors , Treatment Outcome
2.
Neurology ; 78(15): 1150-6, 2012 Apr 10.
Article in English | MEDLINE | ID: mdl-22422896

ABSTRACT

OBJECTIVES: To differentiate onset of CNS involvement in primary hemophagocytic lymphohistiocytosis (HLH) from that of other CNS inflammatory diseases and to identify early symptoms linked to abnormal cognitive outcome. METHODS: Forty-six children with primary HLH who had neurologic evaluation within 2 weeks and brain MRI within 6 months of diagnosis were included. Initial symptoms, CSF study, brain MRI, and neurologic outcome were assessed. Brain MRIs were compared with those of 44 children with acute disseminated encephalomyelitis (ADEM). RESULTS: At disease onset, 29 children (63%) had neurologic symptoms and 7 (15%) had microcephaly. Twenty-three (50%) children had abnormal CSF study, but only 15 (33%) had abnormal brain MRI. The latter showed that patients with HLH, unlike patients with ADEM, had symmetric periventricular lesions, without thalamic and brainstem involvement and with infrequent hyposignal intensity on T1. At the end of follow-up (3.6 ± 3.6 years), 17 of the 28 (61%) surviving patients had normal neurologic status, 5 (18%) had a severe neurologic outcome, and 6 (21%) had mild cognitive difficulties. Abnormal neurologic outcome was not influenced by age or type of genetic defect, but by the presence of neurologic symptoms, MRI lesions, or abnormal CSF study at onset. Early clinical and MRI symptoms may regress after treatment. CONCLUSION: Neurologic symptoms are frequent at the onset of primary HLH and are mostly associated with abnormal CSF findings, but with normal brain MRI. In cases of abnormal brain MRI, the observed lesions differ from those of ADEM.


Subject(s)
Brain/pathology , Brain/physiopathology , Lymphohistiocytosis, Hemophagocytic/pathology , Lymphohistiocytosis, Hemophagocytic/physiopathology , Adolescent , Cerebrospinal Fluid/metabolism , Child , Child, Preschool , Consciousness Disorders/etiology , Diagnosis, Differential , Encephalomyelitis, Acute Disseminated/pathology , Encephalomyelitis, Acute Disseminated/physiopathology , Female , Follow-Up Studies , Humans , Infant , Lymphohistiocytosis, Hemophagocytic/cerebrospinal fluid , Lymphohistiocytosis, Hemophagocytic/complications , Lymphohistiocytosis, Hemophagocytic/psychology , Magnetic Resonance Imaging , Male , Medical Records , Meningism/etiology , Microcephaly/etiology , Microcephaly/pathology , Microcephaly/physiopathology , Retrospective Studies , Seizures/etiology , Treatment Outcome
3.
Gen Hosp Psychiatry ; 28(5): 455-7, 2006.
Article in English | MEDLINE | ID: mdl-16950388

ABSTRACT

INTRODUCTION: We describe three patients with hemophagocytic syndrome (HPS) who developed acute organic brain syndrome. All three presented with high-grade fever and twilight state, and were admitted to our hospital. After admission, delirium developed in all three. As delirium improved, various other psychiatric symptoms, including hallucinations, agitation, hypoactivity, affective lability and insomnia, were noted. DISCUSSION: When treated with steroid hormones, immunoglobulin and neuroleptics, all patients demonstrated improvement in their psychiatric symptoms, as well as in their general condition and laboratory findings. Ultimately, they all recovered and were discharged. CONCLUSION: It needs to be noted that organic brain syndrome might be observed at the onset of HPS. Consequently, early diagnosis and treatment for psychiatric symptoms, as well as for HPS, are crucial.


Subject(s)
Delirium/diagnosis , Delirium/psychology , Lymphohistiocytosis, Hemophagocytic/diagnosis , Lymphohistiocytosis, Hemophagocytic/psychology , Neurocognitive Disorders/diagnosis , Neurocognitive Disorders/psychology , Acute Disease , Aged , Anti-Inflammatory Agents/administration & dosage , Antipsychotic Agents/administration & dosage , Bone Marrow/pathology , Brain/pathology , Delirium/drug therapy , Diagnosis, Differential , Dominance, Cerebral/physiology , Electroencephalography/drug effects , Female , Haloperidol/administration & dosage , Humans , Infusions, Intravenous , Lymphohistiocytosis, Hemophagocytic/drug therapy , Magnetic Resonance Imaging , Male , Methylprednisolone/administration & dosage , Neurocognitive Disorders/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...